Pacing and sensing vectors

• US 9,278,221 B2
• Filed: 05/29/2014
• Issued: 03/08/2016
• Est. Priority Date: 02/08/2001
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stahmann, Jeffrey E., Tockman, Bruce Alan, Westlund, Randy, Wentkowski, Rene H., Anderson, Russell E.
• Primary Examiner(s): Schaetzle, Kennedy
• Application Number:
  US14/290,510
• Publication Number:
  US 20140277236A1
• Time in Patent Office: 649 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold

Abstract

A method for allowing cardiac signals to be sensed and pacing pulse vectors to be delivered between two or more electrodes. In one embodiment, cardiac signals are sensed and pacing pulse vectors are delivered between at least one of a first left ventricular electrode and a second left ventricular electrode. Alternatively, cardiac signals are sensed and pacing pulse vectors are delivered between different combinations of the first and second left ventricular electrodes and a first supraventricular electrode. In addition, cardiac signals are sensed and pacing pulse vectors are delivered between different combinations of the first and second left ventricular electrode, the first supraventricular electrode and a conductive housing. In an additional embodiment, a first right ventricular electrode is used to sense cardiac signals and provide pacing pulses with different combinations of the first and second left ventricular electrodes, the first supraventricular electrode and the housing.

Claims

1. A system for using with a first lead implanted at or near a first region of a left ventricle (LV) of a heart and a second lead implanted at or near a different second region of the heart, the system comp rising:

an implantable medical device (IMD), including;

a controller circuit configured to;

program a first pacing vector including a first anode and a first cathode each selected from two or more electrodes on the first lead or one or more electrodes on the second lead, at least one of the first anode or the first cathode selected from the two or more electrodes on the first lead;

program a second pacing vector including a second anode and a second cathode each selected from the two or more electrodes on the first lead or the one or more electrodes on the second lead, at least one of the second anode and the second cathode selected from the two or more electrodes on the first lead, the second anode different from the first anode or the second cathode different from the first cathode; and

generate a therapy schedule including an indication of temporal relationship between at least a first pacing sequence and a second pacing sequence; and

a pacing output circuit coup led to the first and second leads and the controller circuit, the pacing output circuit configured to, in accordance with the therapy schedule, generate and deliver the first pacing sequence according to the first pacing vector, and generate and deliver the second pacing sequence according to the second pacing vector.

2. The system of claim 1, further comprising:

a first lead configured to be implanted at or near a first region of a left ventricle (LV), the first lead including two or more electrodes adapted to be positioned at or near the first region; and

a second lead configured to be implanted at or near a second region different from the first region, the second lead including one or more electrodes adapted to be positioned at or near the second region.

3. The system of claim 2, wherein the first lead is configured to be intravascularly implanted within a coronary vein at or near the LV.

4. The system of claim 1, wherein the controller circuit is configured to generate a therapy schedule including simultaneous delivery of the first and second pacing sequences.

5. The system of claim 1, wherein the controller circuit is configured to generate a therapy schedule including sequential delivery of the first and second pacing sequences, the second pacing sequence initiated after the first pacing sequence by a specified latency period.

6. The system of claim 1, wherein the controller circuit is configured to:

program the first pacing vector by selecting both the first anode and the first cathode from the two or more electrodes on the first lead;

or

program the second pacing vector by selecting both the second anode and the second cathode from the two or more electrodes on the first lead.

7. The system of claim 1, wherein the second lead is configured to be implanted at or near one of a supraventricular region, a right atrium (RA), or a right ventricle (RV),

and wherein the controller circuit is configured to program at least one of the first and second pacing vectors to include at least one electrode on the second lead, the at least one electrode on the second lead adapted to be positioned at or near one of the supraventricular region, the RA, or the RV.

8. The system of claim 1, wherein the second lead is a defibrillation lead configured to be implanted at the RV, the defibrillation lead including at least one defibrillation coil electrode adapted to be positioned at or near the supraventricular region or the RV, and wherein the controller circuit is configured to program at least one of the first and second pacing vectors to include a combination of the defibrillation electrode on the second lead and one of the two or more electrodes on the first lead.

9. The system of claim 1, wherein the IMD comprises a sensing circuit coupled to the controller circuit, the controller circuit configured to:

program a sensing vector including a combination of electrodes selected from the two or more electrodes on the first lead or the one or more electrodes on the second lead;

control the sensing circuit to sense cardiac electrical activity using the programmed sensing vector; and

generate the therapy schedule based on the sensed cardiac electrical activity.

10. An implantable medical device (IMD) including a non-transitory processor-readable medium comprising instructions that, when performed by the processor, cause the IMD to:

program a first pacing vector by selecting a first anode and a first cathode from two or more electrodes, on a first lead, adapted to be positioned at or near a first region of a left ventricle (LV), or one or more electrodes, on a second lead, adapted to be positioned at or near a second region different from the first region, at least one of the first anode or the first cathode selected from the two or more electrodes on the first lead;

program a second pacing vector by selecting a second anode and a second cathode from the two or more electrodes on the first lead or the one or more electrodes on a second lead, at least one of the second anode and the second cathode selected from the two or more electrodes on the first lead, the second anode different from the first anode or the second cathode different from the first cathode;

generate a therapy schedule including an indication of temporal relationship between at least a first pacing sequence and a second pacing sequence; and

in accordance with the therapy schedule, generate and deliver the first pacing sequence according to the first pacing vector, and generate and deliver the second pacing sequence according to the second pacing vector.

11. The IMD of claim 10, wherein the non-transitory processor-readable medium includes instructions that cause the IMD to generate a therapy schedule including simultaneous delivery of the first and second pacing sequences.

12. The IMD of claim 10, wherein the non-transitory processor-readable medium includes instructions that cause the IMD to generate a therapy schedule including sequential delivery of the first and second pacing sequences, the second pacing sequence initiated after the first pacing sequence by a specified latency period.

13. The IMD of claim 10, wherein the non-transitory processor-readable medium includes instructions that cause the IMD to program the first pacing vector by selecting both the first anode and the first cathode from the two or more electrodes on the first lead, or program the second pacing vector by selecting both the second anode and the second cathode from the two or more electrodes on the first lead.

14. The IMD of claim 10, wherein the non-transitory processor-readable medium includes instructions that cause the IMD to program at least one of the first and second pacing vectors to include a combination of one of the two or more electrodes on the first lead and a defibrillation electrode on the second lead, the defibrillation electrode adapted to be positioned at or near the supraventricular region or the RV.

15. The IMD claim 10, wherein the non-transitory processor-readable medium includes instructions that cause the IMD to:

program a sensing vector including a combination of electrodes selected from the two or more electrodes on the first lead or the one or more electrodes on the second lead;

control the sensing circuit to sense cardiac electrical activity using the programmed sensing vector; and

generate the therapy schedule based on the sensed cardiac electrical activity.

16. A system for using with a lead implanted at or near a left ventricle of a heart, the system comprising a controller circuit configured to deliver pacing signals to the heart via a first left ventricular (LV) electrode and a second LV electrode, wherein the first LV electrode and the second LV electrode are the same electrical polarity and are electrically isolated.

17. The system of claim 16, further comprising a lead configured to be implanted at or near a left ventricle of a heart, wherein the first and second LV electrodes are located on the lead.

18. The system of claim 16, wherein the first LV electrode and the second LV electrode are both cathodes.

19. A system for using with a lead implanted at or near a left ventricle of a heart, the system comprising a controller circuit configured to deliver pacing signals to the heart via a first left ventricular (LV) electrode and a second LV electrode, wherein the first LV electrode and the second LV electrode are the same electrical polarity, and wherein the controller circuit is configured to individually adjust the pacing signals delivered to the heart via the first LV electrode and the second LV electrode.